X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants Business Wire
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment.